Suchergebnisse - "Kopka, Klaus"

PubPharm (577)

1

Combination of [18F]FDG and [18F]PSMA-1007 PET/CT predicts tumour aggressiveness at staging and biochemical failure postoperatively in patients with prostate cancer

enthalten in: European journal of nuclear medicine and molecular imaging | 2024

von Kim, J. | Lee, S. | Kim, D. | +9

2

Improved automated one-pot two-step radiosynthesis of (S)-[18F]FETrp, a radiotracer for PET imaging of indoleamine 2,3-dioxygenase 1 (IDO1)

enthalten in: EJNMMI radiopharmacy and chemistry | 2024

von Maisonial-Besset, A. | Kryza, D. | Kopka, K. | +4

3

Improved automated one-pot two-step radiosynthesis of (S)-[18F]FETrp, a radiotracer for PET imaging of indoleamine 2,3-dioxygenase 1 (IDO1)

enthalten in: EJNMMI radiopharmacy and chemistry | 2024

von Maisonial-Besset, A. | Kryza, D. | Kopka, K. | +4

4

Labeled inhibitors of prostate specific membrane antigen (PSMA) as agents for the treatment of prostate cancer

enthalten in: Europäisches Patentamt | 2024

von EDER MATTHIAS | KOPKA KLAUS | SCHÄFER MARTIN | +4

5

18Fluorine Prostate-specific Membrane Antigen 1007 Positron Emission Tomography for High-risk Prostate Cancer

enthalten in: Urology | 2024

von Froehner, M. | Görner, M. | Merkle, L. | +2

6

Radiosynthesis and biological evaluation of [18F]AG-120 for PET imaging of the mutant isocitrate dehydrogenase 1 in glioma

enthalten in: European journal of nuclear medicine and molecular imaging | 2024

von Lai, T. | Wenzel, B. | Dukić-Stefanović, S. | +11

ErratumIn: Eur J Nucl Med Mol Imaging. 2024 Jan 22;:. - PMID 38252162

7

Correction to : Radiosynthesis and biological evaluation of [18F]AG-120 for PET imaging of the mutant isocitrate dehydrogenase 1 in glioma

enthalten in: European journal of nuclear medicine and molecular imaging | 2024

von Lai, T. | Wenzel, B. | Dukić-Stefanović, S. | +11

ErratumFor: Eur J Nucl Med Mol Imaging. 2024 Mar;51(4):1085-1096. - PMID 37982850

8

LABELED INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA), THEIR USE AS IMAGING AGENTS AND PHARMACEUTICAL AGENTS FOR THE TREATMENT OF PROSTATE CANCER

enthalten in: Europäisches Patentamt | 2024

von EDER MATTHIAS | KOPKA KLAUS | SCHÄFER MARTIN | +7

9

LABELED INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA), THEIR USE AS IMAGING AGENTS AND PHARMACEUTICAL AGENTS FOR THE TREATMENT OF PROSTATE CANCER

enthalten in: Europäisches Patentamt | 2024

von EDER MATTHIAS | KOPKA KLAUS | SCHÄFER MARTIN | +7

10

Correction to: Radiosynthesis and biological evaluation of [18F]AG-120 for PET imaging of the mutant isocitrate dehydrogenase 1 in glioma

enthalten in: European journal of nuclear medicine and molecular imaging | 2024

von Lai, T. | Wenzel, B. | Dukić-Stefanović, S. | +11

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[58]